跳至主要内容
临床试验/CTRI/2024/02/062692
CTRI/2024/02/062692尚未招募Phase 3 4

To evaluate the efficacy and acceptability of the fluoridated toothpaste in its anti-plaque and anti-gingivitis properties in a pediatric population in the age group of 6 to 12 years – A non- randomized active controlled clinical trial.

Avoden pvt ltd5 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年2月26日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
300
试验地点
5
主要终点
Changes in the plaque and gingival scores

研究概览

简要总结

T        The study is a randomized controlled trial to check for the efficacy and acceptability of fluoridated toothpaste in a pediatric population. This study will be conducted across five centers in India with a total sample size of 300 pediatric patients. The primary outcome of the study is changes in the plaque and gingival scores and changes in the clinical signs of gingival inflammation.   The secondary outcome is understanding products acceptability and tolerability through survey data points

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Subjects with plaque score 1 Subjects with gingival scores 1 and 2 Subjects showing signs of mild marginal gingival inflammation Subjects parent or guardian who agree to comply with all study requirements and are able to follow the study directions.

排除标准

  • gingival scores more than 2 orthodontic bands and five or more carious lesions History of allergies Subject on antibiotics Subject with five or more carious lesions requiring immediate restorative treatment.

结局指标

主要结局

Changes in the plaque and gingival scores

时间窗: Plaque and gingival score to be assessed at 1 monthi.e at 1st followup 2 months i.e at2nd followup and 3 months i.e at 3rd followup

Changes in the clinical signs of gingival inflammation

时间窗: Plaque and gingival score to be assessed at 1 monthi.e at 1st followup 2 months i.e at2nd followup and 3 months i.e at 3rd followup

次要结局

  • Understanding products acceptability through survey data points(acceptability and tolerability to be assessed after 1 month)

研究者

发起方
Avoden pvt ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Ashok Dhoble

Indian Dental Association

研究点 (5)

Loading locations...

相似试验